PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Li-Peng Wu

Department of Gastroenterology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, PR China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 6, 2026 · JOURNAL ARTICLE

Drug-Induced liver injury with adebrelimab: how to assess causality using the updated RUCAM?

Future Science Oa

Single case report of adebrelimab-induced liver injury with RUCAM causality assessment; demonstrates clinical utility of diagnostic tool but provides no comparative efficacy data or population estimates.

PreliminaryHeng Xi Immune Checkpoint Inhibitor (icis)Jie Min

Reported

Patient age51 years

Time to jaundice onset after last…4 days

Therapy cycles completed9

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support